Concepedia

Ashish Srivastava

AS

3

Publications

48

Citations

3

H-Index

2017

Active since

Affiliations

Central Drug Research Institute(Current)

Academy of Scientific and Innovative Research

Indian Institute of Toxicology Research

Ashish Srivastava is an author at Central Drug Research Institute specializing in medicine, drug discovery, and tuberculosis prevention.

ORCID

Top concepts

Publications per year

2017–2020

3

Publications

3

Dehydroascorbate-derivatized chitosan particles for targeting antimalarial agents to infected erythrocytes

D.V. Siva Reddy, Tabassum Khan, Rajeev Ranjan et al. · International Journal of Pharmaceutics · 2017 · 21 citations

, , +5

Preparation and optimization of a dry powder for inhalation of second-line anti-tuberculosis drugs

Rajeev Ranjan, Ashish Srivastava, Reena Bharti et al. · International Journal of Pharmaceutics · 2018 · 17 citations

, , +8

Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis

Reena Bharti, Ashish Srivastava, Trisha Roy et al. · Molecular Therapy — Nucleic Acids · 2020 · 10 citations · Full text

Rows per page

1–3 of 3